Found 5 matching trials
Peptide Receptor Radionuclide Therapy (PRRT) in Tumors With High Expression of Somatostatin Receptors (Phase 2)
NAThe rationale behind the purpose of this study lays on:
* the evidence tha...
Location
University Hospital of Ferrara
Neoadjuvant PRRT With 177Lu-DOTATATE Followed by Surgery for Resectable PanNET
PHASE2Peptide Receptor Radionuclide Therapy (PRRT) is based on specific somatosta...
Location
Ospedale San Raffaele
DOTA-TOC in Metastasized Neuroendocrine Tumors
PHASE2The investigators aim to explore the efficacy of \[90Y-DOTA\]-TOC and \[177...
Location
University Hospital
Combination Targeted Radiotherapy in Neuroendocrine Tumors
NAThe primary aim of this project is to determine, what fraction of individua...
Location
University of Iowa
Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents
PHASE1This is a Phase I/II peptide receptor radiotherapy (PRRT) trial of 177Lu-DO...
Location
University of Iowa Hospitals and Clinics